P151 The prediction of Oncotype DX risk group using clinicopathologic factors in patients with HR+/HER2- early breast cancer. (April 2023) - Song, R.; Lee, D.-E.; Lee, S.; Kang, H.-S.; Han, J.H.; Lee, K.S.; Sim, S.H.; Chae, H.; Kwon, Y.; Woo, J.; Lee, M.; Lee, E.-G.; et al.